ENTIS Scientific Committee commentary published: Paternal valproate

A commentary from the ENTIS Scientific Committee has been published in the journal of Pharmacoepidemiology and Drug Safety. Here the members of the committee discuss the recent regulatory recommendations regarding paternal valproate and infant neurodevelopment, and the requirement for data transparency. Read the open access commentary here.